Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (2014-2025) 1.4.2 Wet Age-Related Macular Degeneration (Wet AMD) 1.4.3 Dry Age-Related Macular Degeneration (Dry AMD) 1.5 Market by Application 1.5.1 Global Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2025) 1.5.2 >75 Years  1.5.3 >60 Years  1.5.4 >40 Years 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Wet Age Related Macular Degeneration (AMD) Market Size 2.2 Wet Age Related Macular Degeneration (AMD) Growth Trends by Regions 2.2.1 Wet Age Related Macular Degeneration (AMD) Market Size by Regions (2014-2025) 2.2.2 Wet Age Related Macular Degeneration (AMD) Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Wet Age Related Macular Degeneration (AMD) Market Size by Manufacturers 3.1.1 Global Wet Age Related Macular Degeneration (AMD) Revenue by Manufacturers (2014-2019) 3.1.2 Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Wet Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI) 3.2 Wet Age Related Macular Degeneration (AMD) Key Players Head office and Area Served 3.3 Key Players Wet Age Related Macular Degeneration (AMD) Product/Solution/Service 3.4 Date of Enter into Wet Age Related Macular Degeneration (AMD) Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) 4.2 Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) 5 United States 5.1 United States Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019) 5.2 Wet Age Related Macular Degeneration (AMD) Key Players in United States 5.3 United States Wet Age Related Macular Degeneration (AMD) Market Size by Type 5.4 United States Wet Age Related Macular Degeneration (AMD) Market Size by Application 6 Europe 6.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019) 6.2 Wet Age Related Macular Degeneration (AMD) Key Players in Europe 6.3 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type 6.4 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Application 7 China 7.1 China Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019) 7.2 Wet Age Related Macular Degeneration (AMD) Key Players in China 7.3 China Wet Age Related Macular Degeneration (AMD) Market Size by Type 7.4 China Wet Age Related Macular Degeneration (AMD) Market Size by Application 8 Japan 8.1 Japan Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019) 8.2 Wet Age Related Macular Degeneration (AMD) Key Players in Japan 8.3 Japan Wet Age Related Macular Degeneration (AMD) Market Size by Type 8.4 Japan Wet Age Related Macular Degeneration (AMD) Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019) 9.2 Wet Age Related Macular Degeneration (AMD) Key Players in Southeast Asia 9.3 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Type 9.4 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Application 10 India 10.1 India Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019) 10.2 Wet Age Related Macular Degeneration (AMD) Key Players in India 10.3 India Wet Age Related Macular Degeneration (AMD) Market Size by Type 10.4 India Wet Age Related Macular Degeneration (AMD) Market Size by Application 11 Central & South America 11.1 Central & South America Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019) 11.2 Wet Age Related Macular Degeneration (AMD) Key Players in Central & South America 11.3 Central & South America Wet Age Related Macular Degeneration (AMD) Market Size by Type 11.4 Central & South America Wet Age Related Macular Degeneration (AMD) Market Size by Application 12 International Players Profiles 12.1 Novartis International (Switzerland) 12.1.1 Novartis International (Switzerland) Company Details 12.1.2 Company Description and Business Overview 12.1.3 Wet Age Related Macular Degeneration (AMD) Introduction 12.1.4 Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) 12.1.5 Novartis International (Switzerland) Recent Development 12.2 Bayer (Germany) 12.2.1 Bayer (Germany) Company Details 12.2.2 Company Description and Business Overview 12.2.3 Wet Age Related Macular Degeneration (AMD) Introduction 12.2.4 Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) 12.2.5 Bayer (Germany) Recent Development 12.3 Acucela (US) 12.3.1 Acucela (US) Company Details 12.3.2 Company Description and Business Overview 12.3.3 Wet Age Related Macular Degeneration (AMD) Introduction 12.3.4 Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) 12.3.5 Acucela (US) Recent Development 12.4 Neurotech Pharmaceuticals (US) 12.4.1 Neurotech Pharmaceuticals (US) Company Details 12.4.2 Company Description and Business Overview 12.4.3 Wet Age Related Macular Degeneration (AMD) Introduction 12.4.4 Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) 12.4.5 Neurotech Pharmaceuticals (US) Recent Development 12.5 Ophthotech (US) 12.5.1 Ophthotech (US) Company Details 12.5.2 Company Description and Business Overview 12.5.3 Wet Age Related Macular Degeneration (AMD) Introduction 12.5.4 Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) 12.5.5 Ophthotech (US) Recent Development 12.6 GlaxoSmithKline (US) 12.6.1 GlaxoSmithKline (US) Company Details 12.6.2 Company Description and Business Overview 12.6.3 Wet Age Related Macular Degeneration (AMD) Introduction 12.6.4 GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) 12.6.5 GlaxoSmithKline (US) Recent Development 12.7 Alimera Sciences (US) 12.7.1 Alimera Sciences (US) Company Details 12.7.2 Company Description and Business Overview 12.7.3 Wet Age Related Macular Degeneration (AMD) Introduction 12.7.4 Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) 12.7.5 Alimera Sciences (US) Recent Development 12.8 StemCell (Canada) 12.8.1 StemCell (Canada) Company Details 12.8.2 Company Description and Business Overview 12.8.3 Wet Age Related Macular Degeneration (AMD) Introduction 12.8.4 StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) 12.8.5 StemCell (Canada) Recent Development 12.9 F. Hoffmann-La Roche (Switzerland) 12.9.1 F. Hoffmann-La Roche (Switzerland) Company Details 12.9.2 Company Description and Business Overview 12.9.3 Wet Age Related Macular Degeneration (AMD) Introduction 12.9.4 F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) 12.9.5 F. Hoffmann-La Roche (Switzerland) Recent Development 12.10 Regeneron Pharmaceutical (US) 12.10.1 Regeneron Pharmaceutical (US) Company Details 12.10.2 Company Description and Business Overview 12.10.3 Wet Age Related Macular Degeneration (AMD) Introduction 12.10.4 Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) 12.10.5 Regeneron Pharmaceutical (US) Recent Development 12.11 Allergan (Ireland) 12.12 Adverum Biotechnologies (US) 12.13 Gilead Sciences (US) 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Wet Age Related Macular Degeneration (AMD) Key Market Segments Table Key Players Wet Age Related Macular Degeneration (AMD) Covered Table Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type 2014-2025 Figure Wet Age-Related Macular Degeneration (Wet AMD) Figures Table Key Players of Wet Age-Related Macular Degeneration (Wet AMD) Figure Dry Age-Related Macular Degeneration (Dry AMD) Figures Table Key Players of Dry Age-Related Macular Degeneration (Dry AMD) Table Global Wet Age Related Macular Degeneration (AMD) Market Size Growth by Application 2014-2025 (Million US$) Figure >75 Years  Case Studies Figure >60 Years  Case Studies Figure >40 Years Case Studies Figure Wet Age Related Macular Degeneration (AMD) Report Years Considered Table Global Wet Age Related Macular Degeneration (AMD) Market Size 2014-2025 (Million US$) Figure Global Wet Age Related Macular Degeneration (AMD) Market Size and Growth Rate 2014-2025 (Million US$) Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions 2014-2025 (Million US$) Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions 2014-2019 (Million US$) Table Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions 2014-2019 Figure Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions 2014-2019 Figure Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions 2019 Table Market Top Trends Table Global Wet Age Related Macular Degeneration (AMD) Revenue by Manufacturers (2014-2019) (Million US$) Table Global Wet Age Related Macular Degeneration (AMD) Market Share by Manufacturers (2014-2019) Figure Global Wet Age Related Macular Degeneration (AMD) Market Share by Manufacturers in 2018 Table Global Wet Age Related Macular Degeneration (AMD) Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Wet Age Related Macular Degeneration (AMD) Product/Solution/Service Table Date of Enter into Wet Age Related Macular Degeneration (AMD) Market Table Mergers & Acquisitions, Expansion Plans Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$) Table Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Type (2014-2019) Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2014-2019) Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$) Table Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Application (2014-2019) Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2014-2019) Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Application in 2018 Figure United States Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$) Table United States Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$) Table United States Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019) Table United States Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$) Table United States Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019) Table United States Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$) Table United States Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019) Figure Europe Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$) Table Europe Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$) Table Europe Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019) Table Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$) Table Europe Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019) Table Europe Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$) Table Europe Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019) Figure China Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$) Table China Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$) Table China Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019) Table China Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-20189) (Million US$) Table China Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019) Table China Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$) Table China Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019) Figure Japan Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$) Table Japan Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$) Table Japan Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019) Table Japan Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$) Table Japan Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019) Table Japan Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$) Table Japan Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019) Figure Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019) Table Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019) Table Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019) Figure India Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$) Table India Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$) Table India Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019) Table India Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$) Table India Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019) Table India Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$) Table India Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019) Figure Central & South America Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$) Table Central & South America Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$) Table Central & South America Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019) Table Central & South America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$) Table Central & South America Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019) Table Central & South America Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$) Table Central & South America Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019) Table Novartis International (Switzerland) Company Details Table Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) (Million US$) Figure Novartis International (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) Table Novartis International (Switzerland) Recent Development Table Bayer (Germany) Company Details Table Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$) Figure Bayer (Germany) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) Table Bayer (Germany) Recent Development Table Acucela (US) Company Details Table Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$) Figure Acucela (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) Table Acucela (US) Recent Development Table Neurotech Pharmaceuticals (US) Company Details Table Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$) Figure Neurotech Pharmaceuticals (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) Table Neurotech Pharmaceuticals (US) Recent Development Table Ophthotech (US) Company Details Table Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$) Figure Ophthotech (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) Table Ophthotech (US) Recent Development Table GlaxoSmithKline (US) Company Details Table GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$) Figure GlaxoSmithKline (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) Table GlaxoSmithKline (US) Recent Development Table Alimera Sciences (US) Company Details Table Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$) Figure Alimera Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) Table Alimera Sciences (US) Recent Development Table StemCell (Canada) Company Details Table StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$) Figure StemCell (Canada) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) Table StemCell (Canada) Recent Development Table F. Hoffmann-La Roche (Switzerland) Company Details Table F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$) Figure F. Hoffmann-La Roche (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) Table F. Hoffmann-La Roche (Switzerland) Recent Development Table Regeneron Pharmaceutical (US) Company Details Table Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$) Figure Regeneron Pharmaceutical (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) Table Regeneron Pharmaceutical (US) Recent Development Table Allergan (Ireland) Company Details Table Adverum Biotechnologies (US) Company Details Table Gilead Sciences (US) Company Details Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions (Million US$) 2019-2025 Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Regions (2019-2025) Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Regions in 2025 Figure United States Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD) Figure Europe Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD) Figure China Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD) Figure Japan Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD) Figure India Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD) Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Product (2019-2025) (Million US$) Figure Global Wet Age Related Macular Degeneration (AMD) Market Size by Product (2019-2025) Figure Global Wet Age Related Macular Degeneration (AMD) Market Size by Product in 2025 Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2019-2025) (Million US$) Figure Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2019-2025) Figure Global Wet Age Related Macular Degeneration (AMD) Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Novartis International (Switzerland) Bayer (Germany) Acucela (US) Neurotech Pharmaceuticals (US) Ophthotech (US) GlaxoSmithKline (US) Alimera Sciences (US) StemCell (Canada) F. Hoffmann-La Roche (Switzerland) Regeneron Pharmaceutical (US) Allergan (Ireland) Adverum Biotechnologies (US) Gilead Sciences (US)